Disruptor Series

Healthcare Evolution: Past, Present and Future— Advancing Patient Care in an Era of Accelerating Innovation

 

AB Disruptor Series: Healthcare Evolution: Past, Present and Future— Advancing Patient Care in an Era of Accelerating Innovation

February 19, 2025
Presented by Rick Brink, CFAEdward Bryan, CFAEwa PrzybylkoWentai Xiao
 

Healthcare is undergoing a profound transformation driven by groundbreaking advancements in technology, data and medicine. From predictive analytics and AI-enhanced diagnostics to precision treatments and robotics, these innovations are revolutionizing patient care.

Our latest AB Disruptor Series installment examines how the healthcare industry has evolved through three lenses: pre-diagnosis, diagnosis and treatment. We’ll highlight advances reshaping this “lifecycle of healthcare.” And we’ll offer a forward perspective on what these changes mean for all of us—as patients and investors.

 

What We Discussed

  1. Pre-Diagnosis—On the Road from Reactive to Predictive Care:

    From wearable tech to the ocean of information now available from standard fluid and tissue samples, big data and AI are enabling earlier risk detection and empowering individuals to take control of their health.

  2. Diagnosis—More Precise, More Efficient:

    Technologies such as advanced imaging, molecular diagnostics and AI-powered platforms are advancing disease detection, making diagnoses faster, more accurate and more accessible.

  3. Treatment—Redefining Care with Innovation:

    Genetic sequencing and targeted therapies are driving an evolution from “one size fits all” toward personalization. Robots and automation are advancing across the surgical spectrum, while regenerative medicine and nanotechnology could tackle once-untreatable conditions.

 
 

Sign Up

Receive updates on our quarterly Disruptor Series events 

 
 

Past Topics

The 2024 US presidential election is entrenched as one of the most eventful in the country’s history.

Today’s investment world has been called a “factor zoo,” but value was arguably the first. 

US banks continue to garner headlines—almost a year removed from the heart of the regional crisis, and with the looming end of the Fed’s program to help stop the bleeding.